SE-Therapeutics stands for Self-Entering Therapeutics. We are a company that has conceived an innovative technology for the intracellular delivery of single chain antibodies, and gene editing RNPs. Our mission is to provide life changing cures to patients suffering from incurable diseases such as cancer and neurodegenerative disorders.
Company Details
- Employees
- 7
- Founded
- 2022
- Address
- 4 Rue Pierre Fontaine, Evry,91058,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.se-thx.com
- HQ
- Evry
Se-Therapeutics Questions
Se-Therapeutics's website is http://www.se-thx.com
Se-Therapeutics's LinkedIn profile is https://fr.linkedin.com/company/se-therapeutics
Se-Therapeutics has
7 employees.
View email and phone details for 7
employees at Se-Therapeutics.
Se-Therapeutics's industry is
Biotechnology Research
Se-Therapeutics's top competitors are
Biohive,
Vitropep,
Paris Business Angels,
Huntx Pharma,
Bforcure,
Byorna,
Ags Therapeutics,
Cgenetix,
Abolis Biotechnologies,
Emglev Therapeutics.
Se-Therapeutics's categories are Biotechnology Research
Se-Therapeutics's founding year is 2022
